DOXYCYCLINE - doxycycline capsule

Country: মার্কিন যুক্তরাষ্ট্র

ভাষা: ইংরেজি

সূত্র: NLM (National Library of Medicine)

সক্রিয় উপাদান:

DOXYCYCLINE (UNII: N12000U13O) (DOXYCYCLINE ANHYDROUS - UNII:334895S862)

থেকে পাওয়া:

Bryant Ranch Prepack

INN (International Name):

DOXYCYCLINE

রচনা:

DOXYCYCLINE ANHYDROUS 100 mg

প্রশাসন রুট:

ORAL

প্রেসক্রিপশন টাইপ:

PRESCRIPTION DRUG

থেরাপিউটিক ইঙ্গিত:

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules, USP and other antibacterial drugs, doxycycline capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections:     Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae.     Respiratory tract infections caused by Mycoplasma pneumoniae .     Lymphogranuloma venereum caused by Chlamydia trachomatis .     Psittacosis (ornithosis) caused by Chlamydophila psittaci .     Trachoma caused by Chlamydia trachomatis , although the infec

পণ্য সারাংশ:

Product: 71335-0168 NDC: 71335-0168-1 30 CAPSULE in a BOTTLE NDC: 71335-0168-2 14 CAPSULE in a BOTTLE NDC: 71335-0168-3 20 CAPSULE in a BOTTLE NDC: 71335-0168-4 12 CAPSULE in a BOTTLE NDC: 71335-0168-5 40 CAPSULE in a BOTTLE NDC: 71335-0168-6 10 CAPSULE in a BOTTLE NDC: 71335-0168-7 50 CAPSULE in a BOTTLE

অনুমোদন অবস্থা:

Abbreviated New Drug Application

পণ্য বৈশিষ্ট্য

DOXYCYCLINE - DOXYCYCLINE CAPSULE
BRYANT RANCH PREPACK
----------
DOXYCYCLINE CAPSULES, USP
RX ONLY
TO REDUCE THE DEVELOPMENT OF DRUG-RESISTANT BACTERIA AND MAINTAIN THE
EFFECTIVENESS OF
DOXYCYCLINE CAPSULES AND OTHER ANTIBACTERIAL DRUGS, DOXYCYCLINE
CAPSULES SHOULD BE USED ONLY TO
TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO
BE CAUSED BY BACTERIA.
DESCRIPTION
Doxycycline is a broad-spectrum antibacterial synthetically derived
from oxytetracycline. Doxycycline
capsules USP, 50 mg, 75 mg, and 100 mg contain doxycycline monohydrate
equivalent to 50 mg, 75mg,
and 100 mg of doxycycline for oral administration. The chemical
designation of the light yellow to pale
yellow powder is
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,[4_S_-4α,4aα,5α,5aα,6α,12aα)]-,
monohydrate.
Structural formula:
C
H N O • H O M.W. = 462.45
Doxycycline has a high degree of lipid solubility and a low affinity
for calcium binding. It is highly
stable in normal human serum. Doxycycline will not degrade into an
epianhydro form.
Inert ingredients: colloidal silicon dioxide; magnesium stearate;
microcrystalline cellulose; sodium
starch glycolate; and a hard gelatin capsule which contains titanium
dioxide, FD&C Red # 3, D&C
Yellow # 10, gelatin, sodium lauryl sulfate, for the 50 mg strength;
iron oxide black, iron oxide red,
iron oxide yellow, titanium dioxide, gelatin, sodium lauryl sulfate
for the 75 mg strength and iron oxide
black, iron oxide red, iron oxide yellow, titanium dioxide, FD & C Red
# 3, D&C Yellow # 10, gelatin,
sodium lauryl sulfate for the 100 mg strength. The capsules are
printed with edible ink containing
shellac, titanium dioxide, black iron oxide, brown iron oxide and
potassium hydroxide for 50 mg, 75 mg
and 100 mg strengths.
CLINICAL PHARMACOLOGY
Tetracyclines are readily absorbed and are bound to plasma proteins in
varying degrees. They are
concentrated by the liver in the bile and excreted in the urine and
feces at h